Hyperostosis Frontalis Interna
Synonyms of Hyperostosis Frontalis Interna
- Endostosis Crani
- Hyperostosis Calvariae Interna
- Morgagni-Stewart-Morel Syndrome
- No subdivisions found.
Hyperostosis Frontalis Interna is characterized by the thickening of the frontal bone of the skull. It is not clear that this disorder is actually rare. Some clinicians believe that it may be a common abnormality found in as many as 12 percent of the female population. The disorder may be found associated with a variety of conditions such as seizures, headaches, obesity, diabetes insipidus, excessive hair growth and sex gland disturbances. Increased serum alkaline phosphatase and elevated serum calcium may occur.
The major feature of Hyperostosis Frontalis Interna is excessive growth or thickening of the frontal bone of the head. This excess growth can only be seen in an x-ray. As a result, scientists feel that this condition may be much more prevalent than suspected, but often goes undetected. Many people have no apparent symptoms.
Other conditions that may be found in patients with this disorder are: obesity, a condition in which secondary male sexual traits are acquired by a female (virilization); a central nervous system disorder characterized by a sudden, aimless, uncontrollable discharge of electrical energy in the brain causing a convulsion or loss of consciousness (epilepsy); decreased vision; headaches; disturbances of the ovaries and testes (sex glands or gonads); excessive body hair; and/or diabetes. (For more information on these disorders, choose "Epilepsy" and/or "Diabetes" as your search terms in the Rare Disease Database).
Hyperostosis Frontalis Interna has been found in multiple generations suggesting that the disorder may be inherited as a dominant trait. It is not known if the disorder is autosomal dominant or X-linked. There are no known cases of male-to-male (father to son) transmission.
Human traits, including the classic genetic diseases, are the product of the interaction of two genes, one received from the father and one from the mother.
In dominant disorders, a single copy of the disease gene (received from either the mother or father) will be expressed "dominating" the other normal gene and resulting in the appearance of the disease. The risk of transmitting the disorder from affected parent to offspring is 50 percent for each pregnancy regardless of the sex of the resulting child.
Hyperostosis Frontalis Interna affects females 9 times more often than males. This disorder presents itself most often among the middle-aged and elderly but has also been found in adolescents.
Symptoms of the following disorders can be similar to those of Hyperostosis Frontalis Interna. Comparisons may be useful for a differential diagnosis:
Acromegaly is a slowly progressive, chronic metabolic disorder in which an excess of growth hormone causes abnormal enlargement of various tissues of the body and unusual height. Most conspicuously affected are the extremities, jaws, and face. The enlargement of soft tissue, especially of the heart, is a serious feature of this disorder. High blood pressure (hypertension) may be another serious consequence of Acromegaly. (For more information on this disorder choose "Acromegaly" as your search term in the Rare Disease Database.)
Paget's Disease is a slowly progressive disease of the skeletal system characterized by abnormally rapid bone breakdown and formation, leading to the development of bones that are dense but fragile. This disorder usually affects middle-aged and elderly people and most frequently occurs in the spine, skull, pelvis, thighs and lower legs. When it occurs in the skull it can cause hearing loss. (For more information on this disorder choose "Paget's" as your search term in the Rare Disease Database.)
Leontiasis Ossea or Virchow's Disease is a disorder in which there is an overgrowth of the bones of the face and sometimes of the cranium. This disorder causes a general enlargement and distortion of all the features.
The following disorders have been found in association with Hyperostosis Frontalis Interna. They are not necessary for a differential diagnosis:
Crouzon Disease is a genetic disorder characterized by abnormalities in the skull, face, and brain caused by premature hardening of the skull. The skull is made up of several bony plates initially joined by fibrous connective tissue which normally fuse together and harden over a period of several years after growth of the brain. Facial deformities are often present at birth and may progress with time. Vision disturbances and deafness may develop in some cases. (For more information on this disorder choose "Crouzon" as your search term in the Rare Disease Database.)
Galactorrhea is a condition in which there is a spontaneous flow of milk from the nipple.
Myotonic Dystrophy is an inherited disorder involving the muscles, vision, and endocrine glands. It can cause mental deficiency and loss of hair. Onset of this disorder commonly occurs during young adulthood although it can occur at any age and is extremely variable in degree of severity. Symptoms of this disorder may be tripping, falling, difficulty in moving the neck, lack of facial expression and a nasal sounding voice. (For more information on this disorder choose "Myotonic Dystrophy" as your search term in the Rare Disease Database.)
Diabetes Insipidus is due to an abnormality of anti-diuretic hormone (vasopresin or ADH) originating in the posterior lobe of the pituitary gland. The lack of this hormone on the kidney causes excretion of excessive quantities of very dilute (but otherwise normal) urine. Excessive thirst is the major symptom of this disorder. (For more information on this disorder, choose "Diabetes Insipidus" as your search term in the Rare Disease Database.)
There is no known treatment for Hyperostosis Frontalis Interna. Seizures and headaches can be treated with standard medications.
Genetic counseling may be of benefit for patients and their families. Other treatment is symptomatic and supportive.
Information on current clinical trials is posted on the Internet at www.clinicaltrials.gov. All studies receiving U.S. government funding, and some supported by private industry, are posted on this government web site.
For information about clinical trials being conducted at the NIH Clinical Center in Bethesda, MD, contact the NIH Patient Recruitment Office:
Tollfree: (800) 411-1222
TTY: (866) 411-1010
For information about clinical trials sponsored by private sources, contact:
Organizations related to Hyperostosis Frontalis Interna
Buyse ML. ed. Birth Defects Encyclopedia. Dover, MA; Blackwell Scientific Publications; for: Center for Birth Defects Information Services, Inc;1990:909-910.
Hershkovitz I, et al., Hyperostosis frontalis interna: an anthropological perspective. Am J Phys Anthropol. 1999;109:303-25
Chaljub G, et al., Unusually exuberant hyperostosis frontalis interna: MRI. Neuroradiology. 1999;41:44-45.
Ross AH, et al., Cranial thickness in American females and males. J Forensic Sci. 1998;43:267-72.
Torres MA, et al., Leukocyte-marrow scintigraphy in hyperostosis frontalis interna. J Nucl Med. 1997;38:1283-85.
Akashi T. [MRI findings of hyperostosis frontalis interna--a case of Morgagni syndrome]. No To Shinkei. 1996;48:667-70. Japanese.
FROM THE INTERNET
McKusick, VA. ed. On-line Mendelian Inheritance in Man (OMOM); Entry: 144800, Hyperostosis Frontalis Interna. Creation Date: 6/4/1986. Most recent update: 9/24/94.
The information in NORD’s Rare Disease Database is for educational purposes only. It should never be used for diagnostic or treatment purposes. If you have questions regarding a medical condition, always seek the advice of your physician or other qualified health professional. NORD’s reports provide a brief overview of rare diseases. For more specific information, we encourage you to contact your personal physician or the agencies listed as “Resources” on this report.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.
Copyright ©1992, 1999, 2007
Report last updated: 2007/08/07 00:00:00 GMT+0
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.